Emami Ltd.
Fundamentals
- Market cap
- ₹17,327 cr
- P/E
- 22.35×
- ROE
- 29.93%
- Debt / equity
- 0.02
- Div yield
- 2.47%
- 52-week range
- 376.40 — 634.20
Emami Ltd.
Latest quarter · Mar 2026
Strength & growth
The timeline — 7 notes on Emami Ltd.
May 2026
- 25 May 26 · 5:31 PM IST Brief Brief · Earnings · Mid cap
Emami's Q4 call transcript adds no new numbers beyond the May 21 concall.
A routine disclosure; the forward-looking guidance on summer brands and international recovery was already in the concall summary.
- 21 May 26 · 4:55 PM IST Brief Brief · Concalls · Mid cap
Emami eyes double-digit summer growth, 30% lift in strategic bets
Management's H1 FY27 outlook sees summer brands recovering, international business stabilising, and a portfolio of newer bets targeting 30% growth.
- 21 May 26 · 2:22 PM IST Brief Brief · Earnings · Mid cap
Emami's Q4 results: no new news in investor presentation
Management reiterates resilience in non-summer portfolio, but seasonal headwinds and geopolitical issues weighed on Q4.
- 21 May 26 · 2:21 PM IST Brief Brief · Earnings · Mid cap
Emami's Q4 revenue drops 4% on summer drag; non-summer portfolio up 11%
Unfavourable weather and geopolitical disruptions hit quarterly performance, but the core non-summer portfolio shows resilience.
- 21 May 26 · 2:12 PM IST Brief Brief · Earnings · Mid cap
Emami's audited results show modest profit dip in Q4, FY26
Consolidated PAT down ~11.7% for Q4, ~3.4% for full year. Governance resolutions pass as routine.
- 21 May 26 · 2:02 PM IST Brief Brief · Earnings · Mid cap
Emami's Q4 PAT dips ~12% in routine earnings release
Audited standalone and consolidated numbers for FY26 show a mild dip, while the board reappoints the MD for a second term; no guidance revision or strategic surprise.
- 21 May 26 · 1:55 PM IST Brief Brief · Earnings · Mid cap
Emami's FY26 revenue and profit edge lower; MD reappointed
Consolidated revenue dipped 0.8% and profit 3.4% for the year, while Q4 standalone profit fell 12.3% YoY. The board also reappointed the Vice-Chairman & MD for another five-year term.